Watchlist Price Alert

Fresh Tracks Therapeutics... (FRTX)

NASDAQ: FRTX · Real-Time Price · USD

0.94

0.00 (0.00%)

At close: Feb 28, 2025, 12:19 PM

Fresh Tracks Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-5.69M	-21.1M	-39.47M	-20.91M	-23.88M	-9.24M	-12.96M	-8.97M
Depreciation & Amortization	41K	30K	22K	10K	28K	49K	793K	1.12M
Stock-Based Compensation	1.92M	2.16M	2.26M	1.99M	1.53M	711K	756K	990K
Other Working Capital	-504K	556K	-1.58M	28K	-11.81M	9.36M	4.78M	2.69M
Other Non-Cash Items	60K	-132.01M	2.03M	500K	2.1M	486K	1.66M	990K
Deferred Income Tax	n/a	132.07M	-437K	25K	-2.13M	-244K	n/a	-616K
Change in Working Capital	-669K	-478K	-556K	-1.65M	-13.63M	12.2M	2.81M	-1.9M
Operating Cash Flow	-4.34M	-19.34M	-36.15M	-20.03M	-35.98M	3.97M	-8.6M	-8.39M
Capital Expenditures	n/a	-47K	-36K	-23K	-7K	-12K	-80K	-255K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-1.29M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-45.01M	-36.64M	-38.13M
Sales Maturities Of Investments	n/a	n/a	n/a	4.5M	19.5M	44.69M	31.43M	30.65M
Other Investing Acitivies	n/a	n/a	n/a	4.5M	13.02M	1.61M	n/a	n/a
Investing Cash Flow	n/a	-47K	-36K	4.48M	32.51M	-12K	-5.29M	-7.74M
Debt Repayment	n/a	n/a	n/a	437K	2.59M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-38K	-18K	8.95M	26K	47K	-1.29M	-4K	-14K
Financial Cash Flow	6.53M	1.18M	32.95M	38.44M	2.64M	-1.29M	30.55M	7.74M
Net Cash Flow	2.19M	-18.2M	-3.23M	22.88M	-835K	2.67M	16.65M	-8.38M
Free Cash Flow	-4.34M	-19.38M	-36.18M	-20.06M	-35.99M	3.96M	-8.68M	-8.64M